MTWM
BIIB icon

Masso Torrence Wealth Management’s Biogen BIIB Stock Holding History

Masso Torrence Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-235
Closed -$56K – 99
2021
Q4 		$56K Buy
+235
New +$60.4K 0.04% 144

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Masso Torrence Wealth Management's BIIB Position: Q1 2022 in Review

Masso Torrence Wealth Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 235 shares — an estimated $56K sold.

Masso Torrence Wealth Management first reported a position in BIIB in Q4 2021 and held it in 1 quarter. The position peaked at $56K in Q4 2021. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Masso Torrence Wealth Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Masso Torrence Wealth Management sold 235 Biogen shares in Q1 2022, an estimated $56K.
  • Masso Torrence Wealth Management first reported a position in Biogen in Q4 2021 and held it in 1 quarter.
  • Masso Torrence Wealth Management's Biogen position peaked at $56K in Q4 2021.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Masso Torrence Wealth Management's 13F filing for Q1 2022, filed 26 Apr 2022.